close

Specialty scale-up, product mix: Sun's medicine cabinet piques brokerages

In the near term, higher R&D costs and a recent acquisition to weigh on earnings growth

Ram Prasad Sahu Business Standard Mumbai
Sun Pharma
Premium

Sun Pharma

India’s largest listed pharmaceutical (pharma) company — Sun Pharmaceutical Industries (Sun Pharma) — is expected to maintain its outperformance vis-à-vis the sector’s, as its multi
Or

Also Read

Sun Pharma Q2 PAT rises 10.5% YoY to Rs 2,262 crore on robust sales

Sun Pharma extends gains post September quarter earnings; up 6% in two days

We thrive on products that have limited competition: Top Sun Pharma execs

Sun Pharma Q3 net profit up 5.2% as sales grow in India, US markets

Sun Pharmaceuticals' Halol plant gets 'import alert' from USFDA

Akasa Air launches two new flights from Lucknow to Goa, Ahmedabad

Billionaire mining tycoon Anil Agarwal fights to clear Vedanta's debt

Bharti-backed OneWeb's 36 satellites successfully launched from Sriharikota

Paytm gets extension from RBI for resubmission of PA license application

Social commerce the way to tap growing online buyers from smaller towns

Sun Pharma.Inds.

  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 5Y

First Published: Mar 26 2023 | 4:43 PM IST

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to read more on Business-Standard.com